EP0269677A4 - ASSAYS AND ANTIBODIES FOR N--i(myc) PROTEINS. - Google Patents

ASSAYS AND ANTIBODIES FOR N--i(myc) PROTEINS.

Info

Publication number
EP0269677A4
EP0269677A4 EP19870903573 EP87903573A EP0269677A4 EP 0269677 A4 EP0269677 A4 EP 0269677A4 EP 19870903573 EP19870903573 EP 19870903573 EP 87903573 A EP87903573 A EP 87903573A EP 0269677 A4 EP0269677 A4 EP 0269677A4
Authority
EP
European Patent Office
Prior art keywords
myc
assays
antibodies
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870903573
Other languages
German (de)
French (fr)
Other versions
EP0269677A1 (en
Inventor
Dennis J Slamon
Lawrence M Souza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
University of California
Original Assignee
Amgen Inc
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, University of California filed Critical Amgen Inc
Publication of EP0269677A1 publication Critical patent/EP0269677A1/en
Publication of EP0269677A4 publication Critical patent/EP0269677A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19870903573 1986-05-06 1987-05-05 ASSAYS AND ANTIBODIES FOR N--i(myc) PROTEINS. Withdrawn EP0269677A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86027686A 1986-05-06 1986-05-06
US860276 1986-05-06

Publications (2)

Publication Number Publication Date
EP0269677A1 EP0269677A1 (en) 1988-06-08
EP0269677A4 true EP0269677A4 (en) 1990-03-08

Family

ID=25332853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870903573 Withdrawn EP0269677A4 (en) 1986-05-06 1987-05-05 ASSAYS AND ANTIBODIES FOR N--i(myc) PROTEINS.

Country Status (4)

Country Link
EP (1) EP0269677A4 (en)
JP (1) JP2726264B2 (en)
AU (1) AU596670B2 (en)
WO (1) WO1987006940A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2014473A1 (en) * 1989-04-14 1990-10-14 Hong-Ji Xu Purified, highly specific antibodies against gene products including retinoblastoma and method
EP0513161B1 (en) * 1990-01-26 1995-04-05 Washington Research Foundation Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
EP0471205A1 (en) * 1990-08-15 1992-02-19 E.R. SQUIBB & SONS, INC. Monoclonal antibodies which bind TRK proto-oncogene protein
US5512473A (en) * 1993-01-29 1996-04-30 Brent; Roger Max-interacting proteins and related molecules and methods
US5470955A (en) * 1993-02-02 1995-11-28 Dartmouth College Antibodies which specifically bind mcl-1 polypeptide
JP4417608B2 (en) * 2002-04-25 2010-02-17 花王株式会社 Mutant alkaline cellulase
WO2019025432A1 (en) * 2017-08-01 2019-02-07 Idp Discovery Pharma, S.L. Anticancer peptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000807A1 (en) * 1983-08-17 1985-02-28 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal antibodies to oncoproteins
EP0318179A2 (en) * 1987-11-09 1989-05-31 Progenx, Inc. Use of monoclonal receptors to oncoproteins for monitoring cancer therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000807A1 (en) * 1983-08-17 1985-02-28 Scripps Clinic And Research Foundation Polypeptide-induced monoclonal antibodies to oncoproteins
EP0318179A2 (en) * 1987-11-09 1989-05-31 Progenx, Inc. Use of monoclonal receptors to oncoproteins for monitoring cancer therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8706940A1 *

Also Published As

Publication number Publication date
AU7480387A (en) 1987-12-01
WO1987006940A1 (en) 1987-11-19
JP2726264B2 (en) 1998-03-11
AU596670B2 (en) 1990-05-10
EP0269677A1 (en) 1988-06-08
JPH01501518A (en) 1989-06-01

Similar Documents

Publication Publication Date Title
GB2197322B (en) Antibodies
EP0405578A3 (en) Enzyme immunoassay for antigen and solid phase used therefor
GB8608068D0 (en) Monoclonal antibodies
GB2197323B (en) Antibodies
GB8624899D0 (en) Monoclonal antibodies
AU2420888A (en) Immunoassay for antibodies binding platelets
EP0269677A4 (en) ASSAYS AND ANTIBODIES FOR N--i(myc) PROTEINS.
GB8621910D0 (en) Monoclonal antibodies
GB8715347D0 (en) Monoclonal antibodies
EP0267601A3 (en) Anti-pci monoclonal antibody
GB8616174D0 (en) Monoclonal antibodies
EP0248621A3 (en) Reagent for immunoassay
AU618720B2 (en) Monoclonal antibodies
GB8721276D0 (en) Immunoassay reagents
GB8610203D0 (en) Monoclonal antibodies
GB8610202D0 (en) Monoclonal antibodies
EP0265847A3 (en) Monoclonal antibody
AU7238087A (en) Anti-enzyme antibody immunoassay
GB8710074D0 (en) Antibodies
EP0272691A3 (en) Enzyme immunoassay
GB8619905D0 (en) Monoclonal antibody
AU612122C (en) Monoclonal antibodies
GB2215725B (en) Monoclonal antibodies
AU8003187A (en) Monoclonal antibodies
GB8423816D0 (en) Antibody/antigen protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19880127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19900308

17Q First examination report despatched

Effective date: 19911205

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920619

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SLAMON, DENNIS, J.

Inventor name: SOUZA, LAWRENCE, M.